A Cost-Effectiveness Analysis Comparing Ceftazidime-Avibactam with Meropenem for the Treatment of Hospital-Acquired Pneumonia (Including Ventilator-Associated Pneumonia)
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review
Article in BMJ Global Health (February 2024)